Secondary Prevention in Coronary Heart Disease: Goal Achievement and Drug Prescribing

Author： Giverhaug Trude   Bruland Christine   Trovik Thor  

Publisher： Springer Publishing Company

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.27, Iss.6, 2005-12, pp. : 472-474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Statins for the Primary and Secondary Prevention of Coronary Heart Disease in Women

By  

Current Pharmaceutical Design, Vol. 15, Iss. 10, 2009-04 ,pp. : 1054-1062

Bentham Science Publishers

Access to resources Recommend Favorite

The future of coronary heart disease prevention

By Wald David S  

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 392-396

Royal College Of Physicians

Access to resources Recommend Favorite

Age and Gender Biases in Secondary Prevention of Coronary Heart Disease in a Finnish University Hospital Setting

By Michou Sanna-Maria  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 673-681

Adis International

Access to resources Recommend Favorite

Intensive treatment with high-dose atorvastatin is cost effective in the secondary prevention of coronary heart disease (CHD) in the UK

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Pravastatin: A Pharmacoeconomic Review of its use in Primary and Secondary Prevention of Coronary Heart Disease

By Coukell A.J.   Wilde M.I.  

PharmacoEconomics, Vol. 14, Iss. 2, 1998-08 ,pp. : 217-236

Adis International

Access to resources Recommend Favorite